Related Experiment Video
Updated: Dec 2, 2025
07:00
A Laser-induced Mouse Model of Chronic Ocular Hypertension to Characterize Visual Defects
Published on: August 14, 2013
13.4K
Dense laser at the papillomacular bundle does not cause loss of visual function
Edward Bloch1,2,3, Lyndon da Cruz1,2,3
1NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
European Journal of Ophthalmology
|November 2, 2020
Summary
Juxtapapillary laser (JPL) treatment for optic disc pit maculopathy is safe and effective. This study found no evidence of nerve fiber layer damage or vision loss from dense laser photocoagulation near the papillomacular bundle.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Laser Therapy
Background:
- Juxtapapillary laser (JPL) photocoagulation is standard for optic disc pit maculopathy.
- Concerns persist regarding potential visual function loss despite evidence of safety.
- Hesitancy in treatment can lead to suboptimal protocols.
Purpose of the Study:
- To evaluate the safety and efficacy of dense temporal juxtapapillary endolaser treatment.
- To assess for nerve fiber layer damage and visual function loss after JPL.
Main Methods:
- Observational series of five optic disc pit maculopathy cases.
- Treatment involved dense temporal juxtapapillary endolaser.
- Single tertiary ophthalmic hospital setting.
Main Results:
- No cases showed anatomical or perimetric evidence of nerve fiber layer damage.
- The papillomacular bundle region remained unaffected post-treatment.
Conclusions:
- Dense JPL in the papillomacular bundle vicinity is safe for optic disc pit maculopathy.
- This laser treatment does not cause structural damage or vision loss.
- Appropriate JPL application is a safe and effective therapeutic option for macular pathologies.
Related Concept Videos
01:25Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
01:27Open Angle Glaucoma: Treatment
853
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
853
01:28Angle Closure Glaucoma: Treatment
977
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
977